BMRN vs GROW · P/E 40, rev $1.76B vs P/E 244, rev $14.4M
Biomarin Pharmaceutical Inc (BMRN) versus US Global Investors Inc (GROW) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
US Global Investors Inc (GROW) is a asset management company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported GROW revenue for 2026-06-30 was $14.4M. Net income was $3.1M. Revenue was up 32.8% from 2025-06-30 to 2026-06-30. GROW currently screens at market cap $32.3M and trailing P/E 244.0.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. GROW currently screens at market cap $32.3M and trailing P/E 244.0.
Not investment advice. Open the BMRN and GROW stock pages for the full models.
Not investment advice.